Pressure is on the U.S. to relax marijuana’s legal status
Proponents argue move would advance medical research, ensure safety of products that are legal in some states
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
June 20, 2016 Cover
Volume 94, Issue 25
Proponents argue move would advance medical research, ensure safety of products that are legal in some states
Cover image:
Credit:
Proponents argue move would advance medical research, ensure safety of products that are legal in some states
Annual awards recognize chemical innovations that prevent pollution and promote sustainability
Experts debate controversial paper that suggests delivery efficiencies for cancer nanomedicines are low and not improving
BASF seeks help from academia and computational chemists to make the R&D costs add up
Chemical executives are growing concerned about staffing their expanding companies
Big drugmaker to pay $500 million for biotech firm developing drugs jettisoned by Roche
A protein released by bones activates muscle to metabolize glucose and fatty acids, delaying exhaustion and improving performance